OneMedForum to Highlight the Newest, Most Promising Med Tech Innovations
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
alzheimer’s
Acadia and Biovail Not Giving Up on Parkinson’s Drug
Acadia and its partner Biovail made news last month with a failed late-stage trial of pimavanserin, their experimental drug candidate to treat psychosis related to Parkinson’s disease.
New Developments in Detecting and Treating Alzheimer’s
Every 70 seconds, someone develops Alzheimer’s disease. This startling figure from the Alzheimer’s Association underlines the desperate need for new tools to diagnose and treat this debilitating illness.
FDA to Review Alternative Dosing Method for Bone Marrow Drug
Most people have never heard of myelodysplastic syndrome (MDS), but approximately 10,000 to 15,000 people in the U.S. are diagnosed with it every year.
Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
[Company Profile] Reata Pharmaceuticals
According to the National Kidney Foundation, over 26 million Americans suffer from chronic kidney disease (CKD), a progressive condition in which the kidneys allow waste to build up in the blood.